REBYOTA (fecal microbiota, live-jslm)
FECAL MICROBIOTA THERAPIES · RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION
FERRING LABS
Drug class
Fecal Microbiota Therapies
Fecal microbiota therapies are a class of live biotherapeutic products derived from human stool that are formulated for rectal or oral administration to restore taxonomic diversity and functionality to a disrupted gut microbiome. Read more about Fecal Microbiota Therapies
2 drugs in this class 2 manufacturers
Drugs in Fecal Microbiota Therapies
VOWST (fecal microbiota spores, live-brpk)
FECAL MICROBIOTA THERAPIES · ADJUNCT THERAPY TO PREVENT CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) RECURRENCE
AIMMUNE THERAPE
Filter & compare in the drug finder →
Opens the drug finder with Fecal Microbiota Therapies preselected. Add indication or manufacturer filters there.
Fecal microbiota therapies are a class of live biotherapeutic products derived from human stool that are formulated for rectal or oral administration to restore taxonomic diversity and functionality to a disrupted gut microbiome.
Their primary therapeutic mechanism is the re-establishment of colonization resistance, which repopulates beneficial bacterial communities, repairs metabolic pathways, and inhibits pathogenic proliferation.
Regulatory authorities primarily approve these therapies to prevent recurrent *Clostridioides difficile* infection following antibiotic treatment, while clinical investigations actively evaluate their broader utility in related gastrointestinal and metabolic disorders.
-
fda.gov
Fecal microbiota therapies are a class of live biotherapeutic products derived from human stool that are formulated for rectal or oral administration to restore taxonomic diversity and functionality to a disrupted gut microbiome Their primary therapeutic mechanism is the re-establishment of colonization resistance, which repopulates beneficial bacterial communities, repairs metabolic pathways, and inhibits pathogenic proliferation Regulatory authorities primarily approve these therapies to preve...
-
nih.gov
Fecal microbiota therapies are a class of live biotherapeutic products derived from human stool that are formulated for rectal or oral administration to restore taxonomic diversity and functionality to a disrupted gut microbiome Regulatory authorities primarily approve these therapies to prevent recurrent *Clostridioides difficile* infection following antibiotic treatment, while clinical investigations actively evaluate their broader utility in related gastrointestinal and metabolic disorders
-
ferring.com
Fecal microbiota therapies are a class of live biotherapeutic products derived from human stool that are formulated for rectal or oral administration to restore taxonomic diversity and functionality to a disrupted gut microbiome
-
fda.gov
Their primary therapeutic mechanism is the re-establishment of colonization resistance, which repopulates beneficial bacterial communities, repairs metabolic pathways, and inhibits pathogenic proliferation
-
fallonhealth.org
Their primary therapeutic mechanism is the re-establishment of colonization resistance, which repopulates beneficial bacterial communities, repairs metabolic pathways, and inhibits pathogenic proliferation Regulatory authorities primarily approve these therapies to prevent recurrent *Clostridioides difficile* infection following antibiotic treatment, while clinical investigations actively evaluate their broader utility in related gastrointestinal and metabolic disorders
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.